Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

CAPRICOR THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 28, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

$CAPRPress releaseSep 10, 2026, 10:30 AM ETRead the release

Bernstein Liebhard LLP issued a shareholder-solicitation notice reminding Capricor Therapeutics (NASDAQ: CAPR) investors of a September 28, 2026 lead-plaintiff deadline in a pending securities fraud class action. The underlying suit covers purchasers of CAPR securities between December 17, 2025 and July 6, 2026, alleging materially false and misleading statements about the company's business operations, growth prospects, and financial stability, with certain senior officers named as defendants.

Key figures

Class period end
July 6, 2026
Class period start
December 17, 2025
Firm recoveries claimed
$3.5 billion
Lead plaintiff deadline
September 28, 2026

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.